{"id":533604,"title":"Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-03","captureTimestamp":"2026-03-03T11:33:56.588000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/notice-clarifications-regarding-restricted-drugs-program.html","snippet":"Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP) Date: July 23, 2021 Our file number: 21-113500-270 Key messages Health Canada has proposed regulatory amendments that would restore potential access to restricted drugs Footnote 1…","rawSnapshotUrl":"/api/snapshots/raw/533604","browseUrl":"https://replay.healtharchive.ca/job-6/20260303113356/https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/notice-clarifications-regarding-restricted-drugs-program.html#ha_snapshot=533604","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}